Friday, August 8, 2025

UBS Bypasses Shareholder Vote, Will Acquire Credit Suisse for Over $2 Billion

UBS has finally agreed to acquire troubled Credit Suisse (NYSE: CS) for over $2 billion, following emergency meetings with regulators and the Swiss National Bank that resulted in Swiss authorities agreeing to rewrite governance laws otherwise requiring a crucial shareholder vote.

As first reported by the Financial Times, UBS has reached a deal to buy Credit Suisse for just over $2 billion, substantially below the distraught bank’s closing price of 1.86 Swiss francs on Friday. The Swiss investment bank will now pay just over 0.50 Swiss francs of its own stock— up from a previously rejected offer of 0.25 Swiss francs.

In the meantime, the central bank has agreed to forego a material adverse change clause that would cancel the deal if credit default swaps increase, as well as earmark a $100 billion credit line to UBS. In order for the deal to pass on such short notice, regulators also had to sidestep routine corporate governance rules in order to halt a UBS shareholder vote, that would otherwise take up to six weeks.

However, the fast-tracked plans are receiving criticism by pension fund representatives over regulators’ abrupt and myopic decision making. “I can’t believe our members and UBS shareholders will be happy about this,” Ethos Foundation CEO Vincent Kaufmann told the Financial Times. “I have never seen such measures taken; it shows how bad the situation is.” 

Information for this briefing was found via the Financial Times and the sources mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Gold/Silver: People Can Still Lose Money In This Bull Market!? | Rick Rule

He Said $300 Silver!? | Peter Krauth

Dollar Will Collapse, Gold and Silver Are the Only Safe Havens | Jim Rogers

Recommended

Nova Scotia Bans Forest Access to Prevent Wildfires

Cardiol Therapeutics Releases Positive Topline Results From Phase II Clinical Trial

Related News

Credit Suisse Tumbles As Largest Investor Refuses To Provide Further Support

Credit Suisse (NYSE: CS) is currently attempting to recover from an over 20% tumble at...

Wednesday, March 15, 2023, 11:17:41 AM

Credit Suisse: Bondholders Left Empty-Handed While Equity Holders Get Paid

The details of UBS’ (NYSE: UBS) hastily arranged March 19 acquisition of Credit Suisse (NYSE:...

Monday, March 20, 2023, 03:03:00 PM

Is Credit Suisse Next? Swiss National Bank Ready To Provide Liquidity “If Necessary”

While asserting calm that Credit Suisse (NYSE: CS) “meets the capital and liquidity requirements imposed...

Wednesday, March 15, 2023, 04:06:43 PM

Credit Suisse, HSBC, Others Fined Nearly $400M Over Foreign Currency Market Collusion

European Union regulators have issued fines for four major banks, after an investigation revealed they...

Friday, December 3, 2021, 10:21:00 AM

Saudi National Bank Chair Resigns After Credit Suisse Comment Sparks Bank Run

Ammar Al Khudairy, the chair of Saudi National Bank (SNB), has resigned for “personal reasons”...

Monday, March 27, 2023, 12:17:00 PM